4. 20% incidence of intra-dialytic
hypotension is widely cited .
incidence in cohort studies varies
between 6% and 27% .
In the largest cohort reported so far, 10%
of patients had frequent hypotensive
episodes whereas 13%occasionally had
hypotensive episodes
5. No universally accepted definition
EEBPG working group stresses that both a
reduction in BP, as well as clinical
symptoms with need for nursing
intervention should be present.
A proposed definition is a decrease in
› systolic BP 20mmHg
› a decrease in mean arterial pressure (MAP)
by 10mmHg
› associated with clinical events and need for
nursing
interventions.
6. IDH , a putative causal role in myocardial
and cerebral ischemia.
Independent and negative predictor of
long-term fistula outcome
Causative role in adverse outcome or is
merely a marker of co morbid
conditions, which increase the sensitivity for
IDH.
Impair solute clearance, due to
compartmentalization of blood volume and
premature termination of dialysis sessions
7. Age,
female Gender,
Presence of diabetes mellitus,
Hyperphosphataemia,
Presence of coronary artery disease,
Renal diagnosis other than
glomerulonephritis
use of nitrates
9. Autonomic neuropathy, which can
be assessed using standardized function.
Bradycardia,so called Bezold-Jarish
reflex observed during IDH episodes.
Induction of cytokines, bioincompatibility
of the dialysis membrane, the use of
acetate as dialysate buffer.
10. Hydration of Patient
Dry Weight
Radiological Inv., CT Ratio, IVC diameter
Multi frequency Bio-impedance
BNP level ,Cyclic GMP
17. Temperature primer defect
Low temp can be used in cases of IDH
.5 degree cent be reduced every 15-30
min(Never less than 35 Degree
centigrade)
18. Ultrafiltration Followed by Isovolumic
Dialysis ……Not Rcommended
19. Less common with slow ultra filtration.
Ultrafiltration rate-<10ml/Kg/Hr
Pt with 8hrs dialysis ,thrice a week <1%
Saran R, Bragg-Gresham JL, Levin NW et al. Longer
treatment time and slower ultrafiltration in
hemodialysis: associations with reduced mortality in
the DOPPS. Kidney Int 2006; 69:1222–1228
20. Avoidance of antihypertensive drugs
and prescription of vasoactive
medication
Antihypertensives ..Ca Channel blockers
Nitrates …independent factor.
21. Midodrine is an oral alpha-1 agonist. Its
metabolite
midodrine,desglymidodrine, induces
constriction of both resistance and
capacitance vessels.
Dose 2.5 to 10mg 30 min before Dialysis
Side effects-scalp
parestehesias, heartburn, flushing, headach
e, neck pain and weakness.
22. Lysine vasopressine,
Ergotamine,
Methylene blue
Dobutamine
Insufficient data to make
recommendation
23. L-carnitine levels low.
Because of reduced biosynthesis in the
kidney and losses in the dialysate.
Improves Systolic function
Improved LVEF noted with
supplementation
A study n-223..low IDH
After Dialyisis-20mg/Kg be given
24. Dietary counselling (sodium restriction).
Refraining from food intake during
dialysis.
Clinical reassessment of dry weight.
Use of bicarbonate as dialysis buffer.
Use of a dialysate temperature of
36.58C.
Check dosing and timing of
antihypertensive agents.
25. Try objective methods to assess dry
weight.
Perform cardiac evaluation.
Gradual reduction of dialysate
temperature from 36.8 Deg C downward
(lowest 35 Deg.C)
26. Consider individualized blood volume
controlled feedback.
Prolong dialysis time and/or increase
dialysis frequency.
Prescribe a dialysate calcium
concentration of 1.50 mmol/l.
Mg Concentration .25 mmol/L